Reproductive counselling, treatment and course of pregnancy in 73 German MS patients

Acta Neurologica Scandinavica

Volumn 118, Issue 1, 2008, Pages 24-28

  Hellwig, K ^a   Brune, N ^a   Haghikia, A ^a   Muller T ^a   Schimrigk, S ^a   Schwodiauer V ^b   Gold, R ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b ALFRIED KRUPP KRANKENHAUS   (Germany)

Author keywords

Delivery; Pregnancy; Relapse rate

Indexed keywords

AZATHIOPRINE; BETA1A INTERFERON; GLATIRAMER; IMMUNOGLOBULIN; INTERFERON BETA SERINE;

ADULT; ARTICLE; BREAST FEEDING EDUCATION; CHILDBIRTH; CONTROLLED STUDY; COUNSELING; FEMALE; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PERINATAL PERIOD; PREGNANCY; QUESTIONNAIRE; RELAPSE;

ADJUVANTS, IMMUNOLOGIC; ADULT; COHORT STUDIES; DIRECTIVE COUNSELING; FEMALE; GERMANY; HEALTH CARE SURVEYS; HUMANS; INTERFERON-BETA; MALE; MULTIPLE SCLEROSIS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 44649106934     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2007.00978.x     Document Type: Article

References (15)

1. Orton SM, Herrera BM, Yee IM et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006 5:932 6.
2. Coyle PK, Christie S, Fodor P et al. Multiple sclerosis gender issues: clinical practices of women neurologists. Mult Scler 2004 10:582 8.
3. Dwosh E, Guimond C, Duquette P, Sadovnick AD. The interaction of MS and pregnancy: a critical review. Int MS J 2003 10:38 42.
4. Ferrero S, Pretta S, Ragni N. Multiple sclerosis: management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol 2004 115:3 9.
5. Filippi M, Rovaris M, Inglese M et al. Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet 2004 364:1489 96.
6. Hoffmann LA, Kumpfel T, Heer I, Hohlfeld R. Pregnancy and immunomodulatory therapy in multiple sclerosis patients. Nervenarzt 2006 77:663 8, 670.
7. Kappos L, Polman CH, Freedman MS et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 2006 67:1242 9.
8. Kinkel RP, Kollman C, O'Connor P et al. IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event. Neurology 2006 66:678 84.
9. Vukusic S, Hutchinson M, Hours M et al. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 2004 127:1353 60.
10. Greenberger PA, Odeh YK, Frederiksen MC, Atkinson AJ Jr. Pharmacokinetics of prednisolone transfer to breast milk. Clin Pharmacol Ther 1993 53:324 8.
11. Achiron A, Kishner I, Dolev M et al. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J Neurol 2004 251:1133 7.
12. de Seze J, Chapelotte M, Delalande S, Ferriby D, Stojkovic T, Vermersch P. Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis. Mult Scler 2004 10:596 7.
13. Dahl J, Myhr KM, Daltveit AK, Hoff JM, Gilhus NE. Pregnancy, delivery, and birth outcome in women with multiple sclerosis. Neurology 2005 65:1961 3.
14. Boskovic R, Wide R, Wolpin J, Bauer DJ, Koren G. The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort. Neurology 2005 65:807 11.
15. Vukusic S, Confavreux C. Pregnancy and multiple sclerosis: the children of PRIMS. Clin Neurol Neurosurg 2006 108:266 70.